The Cancer Letter

Inside information on cancer research and drug development

Vol.
24
No.
42
November 06, 1998Nov 06, 1998
Free
DOWNLOAD THE PDF

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

Review Group Report: NCI Role In Drug Development Seen As Information Provider

NCI Offers Model Informed Consent Documents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account